Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 347
6
Diseases
5
Unique genes
0.297
Avg. similarity score
Congenital facial anomaly
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Congenital facial anomaly
Carbamoyl phosphate synthetase deficiency
Congenital hypoplastic anemia
Hypoplastic anemia
developmental and epileptic encephalopathy, 50
Thauvin-robinet-faivre syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Congenital facial anomaly | 5 | 5 | 3 |
| Carbamoyl phosphate synthetase deficiency | 4 | 4 | 2 |
| Congenital hypoplastic anemia | 4 | 4 | 2 |
| Hypoplastic anemia | 4 | 4 | 2 |
| developmental and epileptic encephalopathy, 50 | 4 | 4 | 1 |
| Thauvin-robinet-faivre syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CAD | 5 / 6 | Carbamoyl phosphate synthetase deficiency, Congenital facial anomaly, Congenital hypoplastic anemia, developmental and epileptic encephalopathy, 50 and 1 more |
| FIBP | 2 / 6 | Congenital facial anomaly, Thauvin-robinet-faivre syndrome |
| UMPS | 2 / 6 | Congenital hypoplastic anemia, Hypoplastic anemia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Pyrimidine biosynthesis | Reactome | 2 / 3 | 1,601× | 4.16e-7 | 2.28e-5 ✓ sig. |
| Arginine biosynthesis | KEGG | 2 / 23 | 209× | 3.50e-5 | 9.50e-4 ✓ sig. |
| Alanine, aspartate and glutamate metabolism | KEGG | 2 / 37 | 130× | 9.18e-5 | 2.09e-3 ✓ sig. |
| Pyrimidine metabolism | KEGG | 2 / 58 | 82.8× | 2.27e-4 | 4.33e-3 ✓ sig. |
| Biosynthesis of cofactors | KEGG | 2 / 154 | 31.2× | 1.59e-3 | 1.93e-2 ✓ sig. |
| HuR (ELAVL1) binds and stabilizes mRNA | Reactome | 1 / 8 | 300× | 3.33e-3 | 3.31e-2 ✓ sig. |
| Urea cycle | Reactome | 1 / 10 | 240× | 4.16e-3 | 3.87e-2 ✓ sig. |
| Nitrogen metabolism | KEGG | 1 / 17 | 141× | 7.06e-3 | 5.49e-2 |
| Transport of Ribonucleoproteins into the Host Nucleus | Reactome | 1 / 31 | 77.5× | 1.28e-2 | 7.92e-2 |
| NEP/NS2 Interacts with the Cellular Export Machinery | Reactome | 1 / 31 | 77.5× | 1.28e-2 | 7.92e-2 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | Reactome | 1 / 31 | 77.5× | 1.28e-2 | 7.92e-2 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | Reactome | 1 / 31 | 77.5× | 1.28e-2 | 7.92e-2 |
| Vpr-mediated nuclear import of PICs | Reactome | 1 / 33 | 72.8× | 1.37e-2 | 8.23e-2 |
| Transport of the SLBP independent Mature mRNA | Reactome | 1 / 34 | 70.6× | 1.41e-2 | 8.38e-2 |
| SUMOylation of SUMOylation proteins | Reactome | 1 / 34 | 70.6× | 1.41e-2 | 8.38e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| 'de novo' pyrimidine nucleobase biosynthetic process | GO:0006207 | 3 / 6 | 1,869× | 1.84e-10 | 4.96e-8 ✓ sig. |
| 'de novo' UMP biosynthetic process | GO:0044205 | 2 / 3 | 2,492× | 1.72e-7 | 1.91e-5 ✓ sig. |
| citrulline biosynthetic process | GO:0019240 | 2 / 4 | 1,869× | 3.44e-7 | 3.40e-5 ✓ sig. |
| UDP biosynthetic process | GO:0006225 | 2 / 5 | 1,495× | 5.73e-7 | 5.25e-5 ✓ sig. |
| pyrimidine nucleotide biosynthetic process | GO:0006221 | 2 / 9 | 831× | 2.06e-6 | 1.47e-4 ✓ sig. |
| response to amine | GO:0014075 | 2 / 10 | 747× | 2.58e-6 | 1.76e-4 ✓ sig. |
| glutamine metabolic process | GO:0006541 | 2 / 15 | 498× | 6.01e-6 | 3.47e-4 ✓ sig. |
| response to starvation | GO:0042594 | 2 / 37 | 202× | 3.80e-5 | 1.46e-3 ✓ sig. |
| liver development | GO:0001889 | 2 / 87 | 85.9× | 2.12e-4 | 5.27e-3 ✓ sig. |
| carbamoyl phosphate biosynthetic process | GO:0070409 | 1 / 1 | 3,737× | 2.68e-4 | 6.20e-3 ✓ sig. |
| response to oleic acid | GO:0034201 | 1 / 2 | 1,869× | 5.35e-4 | 9.98e-3 ✓ sig. |
| monoatomic anion homeostasis | GO:0055081 | 1 / 2 | 1,869× | 5.35e-4 | 9.98e-3 ✓ sig. |
| pyrimidine-containing compound biosynthetic process | GO:0072528 | 1 / 2 | 1,869× | 5.35e-4 | 9.98e-3 ✓ sig. |
| cellular response to oleic acid | GO:0071400 | 1 / 3 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| UMP biosynthetic process | GO:0006222 | 1 / 3 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |